Exhaled nitric oxide (NO) originates from the upper airways, and takes action, to varying
extents, in regulation, protection and defense, as well as in noxious processes. Nitric oxide …

Nitric oxide (NO) is produced within the airways and released with exhalation. Nasal NO
(nNO) can be measured in a non-invasive way, with different devices and techniques …

Nitric oxide (NO), the highly reactive radical gas, provides an attractive strategy in the control
of microbial infections. NO not only exhibits bactericidal effect at high concentrations but also …

Significant advances have been made in the diagnosis of patients with primary ciliary
dyskinesia (PCD) including centralised services [ 1–3], European consensus guidelines [4] …

Background Early diagnosis and monitoring of disease activity are essential in cystic fibrosis
(CF) and primary ciliary dyskinesia (PCD). We aimed to establish exhaled molecular profiles …

Primary ciliary dyskinesia is a genetic disease of ciliary function leading to chronic upper
and lower respiratory tract symptoms. The diagnosis is frequently overlooked because the …

Bronchiectasis represents the final pathway of several infectious, genetic, immunologic or
allergic disorders. Accurate and prompt identification of the underlying cause is a key …

Primary ciliary dyskinesia (PCD) is a genetic disease characterized by abnormalities in
ciliary function, leading to compromised airway clearance and chronic bacterial infection of …

Diagnosing primary ciliary dyskinesia is difficult. With no reference standard, a combination
of tests is needed; most tests require expensive equipment and specialist scientists. We …

Primary ciliary dyskinesia (PCD) is a genetic condition affecting approximately 1 in 15,000–
20,000 individuals, and the majority of cases exhibit an autosomal recessive inheritance …